EP2849723

GENENTECH, INC.
Application Number
EP13724493A
Filing Date
May 17, 2013
Status
Opposition Rejected
Oct 8, 2021
Grant Date
May 2, 2018
External Links
Slate, Register

Biblio Summary

The patent EP2849723B1 was granted on May 2, 2018 by Genentech, Inc. The patent is currently Opposition Rejected.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BAYER INTELLECTUAL PROPERTY GMBH / BAYER AKTIENGESELLSCHAFTJan 31, 2019ADMISSIBLE

The table below shows the patents of Genentech, Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2694072Combinations Of Akt Inhibitor Compounds And Abiraterone, And Methods Of UseAug 7, 20241
EP4108259Process For Concentration Of Antibodies And Therapeutic Products ThereofJan 3, 20241
EP3589661Adjuvant Treatment Of Her2-Positive Breast CancerNov 1, 20234

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.